Asia Pacific Prenatal & Newborn Genetic Testing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Prenatal & Newborn Genetic Testing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Prenatal & Newborn Genetic Testing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Prenatal & Newborn Genetic Testing Market Regional Analysis

6.2 Asia Pacific Prenatal & Newborn Genetic Testing Market Revenue 2016-2027 (US$ Million)

6.3 Asia Pacific Prenatal & Newborn Genetic Testing Market Forecast Analysis

7. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Product

7.1 Diagnostic

7.1.1 Overview
7.1.2 Diagnostic: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Screening

7.2.1 Overview
7.2.2 Screening: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Disease Indication

8.1 Cystic Fibrosis

8.1.1 Overview
8.1.2 Cystic Fibrosis: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Sickle Cell Anemia

8.2.1 Overview
8.2.2 Sickle Cell Anemia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.3 Down Syndrome

8.3.1 Overview
8.3.2 Down Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.4 Phenylketonuria

8.4.1 Overview
8.4.2 Phenylketonuria: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.5 Recurrent Pregnancy Loss

8.5.1 Overview
8.5.2 Recurrent Pregnancy Loss: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.6 Antiphospholipid Syndrome

8.6.1 Overview
8.6.2 Antiphospholipid Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.7 Other Diseases

8.7.1 Overview
8.7.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Technology

9.1 Spectrophotometer

9.1.1 Overview
9.1.2 Spectrophotometer: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Polymerase Chain Reaction

9.2.1 Overview
9.2.2 Polymerase Chain Reaction: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.3 Fluorescence In-situ Hybridization

9.3.1 Overview
9.3.2 Fluorescence In-situ Hybridization: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.4 Array Comparative Genomic Hybridization

9.4.1 Overview
9.4.2 Array Comparative Genomic Hybridization: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by End User

10.1 Hospitals & Clinics

10.1.1 Overview
10.1.2 Hospitals & Clinics: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

10.2 Diagnostic Centers

10.2.1 Overview
10.2.2 Diagnostic Centers: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

10.3 Other End User

10.3.1 Overview
10.3.2 Other End User: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

11. Asia Pacific Prenatal & Newborn Genetic Testing Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Key Country, 2019 and 2027 (%)
11.2.1.1 Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
11.2.1.1.2 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
11.2.1.1.3 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
11.2.1.1.4 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

11.2.1.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
11.2.1.2.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
11.2.1.2.3 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
11.2.1.2.4 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

11.2.1.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
11.2.1.3.2 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
11.2.1.3.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
11.2.1.3.4 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

11.2.1.4 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
11.2.1.4.2 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
11.2.1.4.3 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
11.2.1.4.4 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 LifeCell

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Quest Diagnostics Incorporated

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Medgenome

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Eurofins Scientific

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Metropolis India

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 SRL Diagnostics

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sandor Lifesciences Pvt Ltd

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 PerkinElmer, Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Natera, Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Laboratory Corporation of America Holdings (Sequenom)

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Genes2Me LLP

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Illumina, Inc.

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Prenatal & Newborn Genetic Testing Market